Glycine (CHNO) is a non-optical, non-polar, glucogenic amino acid that is naturally found in several protein-rich foods, such as fish, dairy, legumes, and meat. It is colorless, water-soluble, has a sweet taste, and is widely used in the pharmaceutical industry. Glycine is produced from serine, choline, hydroxyproline, and threonine using interorgan metabolism where kidneys and liver are involved. It is considered a building block of protein, which is why it is used as an amino acid to make protein in the human body. It is largely used to treat obesity, cancer, cardiovascular diseases (CVDs), schizophrenia, stroke, sleeping disorder, metabolic syndrome, and rare inherited metabolic disorders. It is also incorporated as a dietary supplement in animal feed to regulate the metabolic process. Additionally, glycine is a rich source of antioxidants and creatine and can protect the liver from alcohol-induced damage, regulate sleep, and protect against muscle loss.
The global glycine market is primarily driven by the escalating prevalence of anxiety disorder. Glycine is largely used in the manufacturing of medications for anxiety disorders. Furthermore, the rising ownership of pet dogs and cats and a surging trend of pet humanization have significantly increased the expenditure on pet care, which is positively supporting the market growth. Moreover, the rapid adoption of genetically modified (GM) and herbicide-tolerant (HT) crops and the shifting emphasis on improving crop yield and sophisticated farming practices are boosting the market growth. Apart from this, the increasing demand for crop protection solutions in agriculture and rising research and development (R&D) activities by the key players are creating a positive outlook for the market. Additionally, governments of various nations are undertaking several initiatives to increase cattle population and raise breeding activities, which is estimated to accelerate the demand for glycine. Other factors, such as the growing use of glycine as an emulsifier, sweetener, emollient, stabilizer, solubilizing agent, and buffer substance in various applications and the rapidly expanding pharmaceutical sector, are providing an impetus to the market growth.
This production cost analysis report by Syndicated Analytics is the result of a comprehensive examination of the glycine manufacturing process. The study covers all the requisite aspects that one needs to know while making a foray into the glycine industry. It is based on the latest economic data and presents exhaustive insights about the primary process flow, raw material requirements, reactions involved, utility costs, operating costs, capital investments, pricing, margins, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake in the glycine industry.
The following technical and economic aspects are included in the report:
Key Questions Answered in This Report-
Need a Customized Project Report?
Although we have tried to make the report as comprehensive as possible, we believe that every stakeholder may have their specific requirements. In view of this, we can customize the report based on your particular needs. You can share your business requirements with our consultants, and we will provide you a tailored scope. Some of the common customizations that our clients request us include:
Why buy Syndicated Analytics reports
Personalize this research
Triangulate with your own data
Get data as per your format and definition
Gain a deeper dive on a specific application, geography, customer or competitor
Any level of personalization
© Copyright Syndicated Analytics 2023.